Macquarie Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-74,474
Closed -$9.83M 1800
2025
Q1
$9.83M Sell
74,474
-470,058
-86% -$62M 0.01% 810
2024
Q4
$45.5M Sell
544,532
-162,169
-23% -$13.5M 0.06% 440
2024
Q3
$51.7M Sell
706,701
-304,565
-30% -$22.3M 0.06% 440
2024
Q2
$69.3M Sell
1,011,266
-451,114
-31% -$30.9M 0.08% 324
2024
Q1
$101M Sell
1,462,380
-101,773
-7% -$7.04M 0.11% 239
2023
Q4
$112M Buy
1,564,153
+196,778
+14% +$14.1M 0.13% 223
2023
Q3
$71.2M Buy
1,367,375
+348,978
+34% +$18.2M 0.09% 301
2023
Q2
$64.5M Buy
1,018,397
+568,397
+126% +$36M 0.07% 351
2023
Q1
$24.4M Hold
450,000
0.03% 617
2022
Q4
$23.8M Sell
450,000
-1,920
-0.4% -$102K 0.03% 657
2022
Q3
$21.1M Sell
451,920
-74,053
-14% -$3.45M 0.03% 671
2022
Q2
$30M Buy
525,973
+73,801
+16% +$4.21M 0.03% 605
2022
Q1
$27.7K Buy
452,172
+731
+0.2% +$45 0.02% 685
2021
Q4
$23.6M Hold
451,441
0.02% 715
2021
Q3
$16.8M Hold
451,441
0.01% 814
2021
Q2
$18.4M Sell
451,441
-723
-0.2% -$29.5K 0.02% 802
2021
Q1
$15.3M Sell
452,164
-726
-0.2% -$24.6K 0.02% 617
2020
Q4
$14.4M Hold
452,890
0.02% 614
2020
Q3
$11.6M Buy
452,890
+170,000
+60% +$4.36M 0.02% 609
2020
Q2
$7.26M Buy
282,890
+47,890
+20% +$1.23M 0.01% 701
2020
Q1
$3.61M Buy
235,000
+135,000
+135% +$2.07M 0.01% 786
2019
Q4
$3.43M Hold
100,000
﹤0.01% 897
2019
Q3
$747K Sell
100,000
-7,616
-7% -$56.9K ﹤0.01% 1294
2019
Q2
$1.4M Buy
107,616
+32,800
+44% +$426K ﹤0.01% 1119
2019
Q1
$911K Hold
74,816
﹤0.01% 1219
2018
Q4
$852K Buy
74,816
+22,300
+42% +$254K ﹤0.01% 1193
2018
Q3
$1.14M Sell
52,516
-2,889
-5% -$62.7K ﹤0.01% 1175
2018
Q2
$979K Sell
55,405
-374
-0.7% -$6.61K ﹤0.01% 1185
2018
Q1
$1.17M Buy
55,779
+53,679
+2,556% +$1.13M ﹤0.01% 1132
2017
Q4
$30K Buy
+2,100
New +$30K ﹤0.01% 2176
2017
Q2
Sell
-40,863
Closed -$664K 1554
2017
Q1
$664K Sell
40,863
-2,637
-6% -$42.9K ﹤0.01% 1269
2016
Q4
$656K Buy
43,500
+19,900
+84% +$300K ﹤0.01% 1272
2016
Q3
$360K Sell
23,600
-23,600
-50% -$360K ﹤0.01% 1348
2016
Q2
$1.83M Buy
+47,200
New +$1.83M ﹤0.01% 1164